BEIJING, SHANGHAI and BOSTON, Jan. 6, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed KRAS G12C inhibitor glecirasib has been...
Read More Details
Finally We wish PressBee provided you with enough information of ( The Registrational Clinical Data of Glecirasib was Published in Nature Medicine )
Also on site :
- Syrian Ministry of Communications launches SilkLink project to develop internet
- Armed man shot by LAPD after confrontation in Tarzana
- Will the US-China tariff deal avert a possible global trade war?